Разработка и регистрация лекарственных средств is a peer-reviewed russian-language open-access journal published by LLC Center of Pharmaceutical Analytics (LLC «CPHA») in Russian Federation, operating under an open-access model since 2016. The journal covers Industries. Land use. Labor: Special industries and trades: Pharmaceutical industry.
Authors publish in Разработка и регистрация лекарственных средств without paying any article processing charge (APC) — making it a fully diamond/platinum open-access venue, supported entirely by its publisher or sponsor. Articles are released under the CC BY, Publisher's own license license (see other journals using this license).
To date, Разработка и регистрация лекарственных средств has published 656 articles. Articles are minted with DOIs through the prefix 10.33380. All submissions undergo plagiarism screening before peer review.
Keywords
acute toxicity, antimicrobial activity, bioavailability, bioequivalence, clinical trials, drugs
At a glance
- Country
- Russian Federation
- Primary language
- Russian
- License
- CC BY, Publisher's own license
- Peer review
- Double anonymous peer review
- OA since
- 2016
- Review time
- 8 weeks
- DOI prefix
10.33380- Plagiarism check
- Yes
ISSN
- 2305-2066
- electronic
- 2658-5049
Frequently asked questions
Is Разработка и регистрация лекарственных средств peer-reviewed?
Does Разработка и регистрация лекарственных средств charge an article processing charge (APC)?
What subjects does Разработка и регистрация лекарственных средств publish?
What languages does Разработка и регистрация лекарственных средств accept?
What is the ISSN of Разработка и регистрация лекарственных средств?
2305-2066 (print) · 2658-5049 (electronic).